Evidence map›Paper›PMID 41589696›Full record

ArticleThe journal of physical chemistry. B2026

Atomistic Insights into Structure and Properties of ε-Caprolactone Oligomers.

Mai Ahmed, Deniz Yilmaz, Purushottam Poudel, Felix H Schacher, Eva Perlt

Abstract read
In one paragraph

Article in The journal of physical chemistry. B, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mai AhmedInstitute of Organic Chemistry and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena, Humboldtstraße 10, 07743 Jena, Germany.
Deniz YilmazInstitute of Organic Chemistry and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena, Humboldtstraße 10, 07743 Jena, Germany.ORCID 0009-0000-6291-4076
Purushottam PoudelHIPOLE Jena (Helmholtz Institute for Polymers in Energy Applications Jena), Lessingstrasse 12-14, 07743 Jena, Germany.ORCID 0000-0002-2452-2634
Felix H SchacherInstitute of Organic Chemistry and Macromolecular Chemistry (IOMC), Friedrich Schiller University Jena, Humboldtstraße 10, 07743 Jena, Germany.ORCID 0000-0003-4685-6608
Eva PerltOtto Schott Institute of Materials Research (OSIM), Faculty of Physics and Astronomy, Friedrich Schiller University Jena, Löbdergraben 32, 07743 Jena, Germany.ORCID 0000-0002-4670-0542

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The design of functional and sustainable materials requires a detailed understanding of the material properties and degradation mechanisms. In particular, the design of fully biodegradable polymers could allow a quick and controlled decomposition of materials before they accumulate in the environment and break down to micro- and nanoplastics. An important degradation pathway proceeds via the hydrolysis of polyesters. To obtain the best performing material candidates, a multiscale-level understanding that takes into account electronic structure combined with multiple configurations at the macroscopic scale is necessary. In this contribution, we present the extension of the multiscale Quantum Cluster Equilibrium method to oligomer materials. We showcase the first application of this methodology to oligomer systems, in particular oligo(ε-Caprolactone). The ε-Caprolactone oligomers were synthesized and characterized comprehensively by means of NMR, SEC, DSC, and TGA. Experimentally, two melting temperatures were observed, which were predicted by theoretical calculations and are in convincing agreement.

Identifiers

PMID41589696
PMCPMC12884469

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.